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Questions: In people with Parkinson’s disease, does home-based prescribed exercise improve balance-related
activities and quality of life compared with no intervention? Are the effects of home-based exercise similar to
those of equivalent centre-based exercise? Design: Systematic review and meta-analysis of randomised and
quasi-randomised controlled trials. Participants: Adults diagnosed with idiopathic Parkinson’s disease.
Intervention: Predominantly home-based prescribed exercise (deﬁned as a minimum of two-thirds of the
exercise being completed at home). The intervention had to primarily involve physical practice of exercises
targeting gait and/or standing balance compared with either control (ie, usual care only, a sham intervention
or no physiotherapy) or equivalent predominantly centre-based exercise. Outcome measures: The primary
outcome was balance-related activities and the secondary outcomes were gait speed, Berg Balance Scale,
Functional Reach test, and quality of life. Results: Sixteen trials met the inclusion criteria and all contributed
to the meta-analyses. Twelve trials compared home-based prescribed exercise with control, and four trials
compared home-based prescribed exercise with equivalent centre-based exercise. Home-based prescribed
exercise improved balance-related activities (SMD 0.21, 95% CI 0.10 to 0.32) and gait speed (SMD 0.30, 95% CI
0.12 to 0.49), but not quality of life (SMD 0.11, 95% CI 20.01 to 0.23) compared with control. Home-based and
centre-based exercise had similar effects on balance-related activities (SMD 20.04, 95% CI 20.36 to 0.27) and
quality of life (SMD 20.08, 95% CI 20.41 to 0.24). Conclusion: Home-based prescribed exercise improves
balance-related activities and gait speed in people with Parkinson’s disease, and these improvements are
similar to improvements with equivalent centre-based exercise. Registration: PROSPERO CRD 42018107331.
[Flynn A, Allen NE, Dennis S, Canning CG, Preston E (2019) Home-based prescribed exercise improves
balance-related activities in people with Parkinson’s disease and has beneﬁts similar to centre-based
exercise: a systematic review. Journal of Physiotherapy 65:189–199]
© 2019 Australian Physiotherapy Association. Published by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Parkinson’s disease is a chronic, progressive, neurodegenerative
disorder. It is the fastest growing neurological disorder in the world;
the number of people with Parkinson’s disease is projected to double
from 6 million in 2015 to 12 million in 2040.1 Physiotherapy in-
terventions such as balance exercises, treadmill training, cueing and
strength exercise have become an integral part of the management of
Parkinson’s disease.2 High-quality systematic reviews and rando-
mised controlled trials have shown that exercise improves mobility
(gait speed, step length and walking capacity),3–5 balance6,7 and
quality of life,3 and can reduce falls.8,9
Questions remain, however, about the optimal location, amount of
supervision, mode of delivery (individual, group or both), intensity,
duration and type of exercise required to achieve these beneﬁts.
These questions arise due to the wide range of prescribed exercise
used in research, with the location and amount of supervision varyingn. Published by Elsevier B.V. This isacross studies.10 The prescribed exercise that has been reported in-
cludes: individual centre-based or home-based programs; supervised
group sessions at a centre; home exercise programs with minimal
supervision; and a combination of supervised centre-based sessions
and home exercise programs.10 Given the progressive nature of Par-
kinson’s disease combined with near-normal life expectancy,11 it is
imperative that prescribed exercise programs for people with Par-
kinson’s disease are sustainable and effective over a long period of
time. Home-based prescribed exercise, where the exercise is
completed in the person’s home, is one model of care that has the
potential to be sustained over a long period of time with minimal
resources. To date, no systematic reviews have speciﬁcally investi-
gated the effectiveness of home-based prescribed exercise for people
with Parkinson’s disease.
A few small randomised controlled trials have aimed to identify if
location impacts on the effectiveness of prescribed exercise, by
comparing home-based and centre-based interventions of similaran open access article under the CC BY-NC-ND license (http://creativecommons.org/
Box 1. Inclusion criteria.
Design
 Randomised or quasi-randomised controlled trials
Participants
 Adults with Parkinson’s disease
Intervention
 Involved predominantly home-based prescribed exercise
  4 sessions over  2 weeks
 Prescribed by a physiotherapist or health professional with a degree-level qualification in exercise prescription
 Primarily involved physical practice of exercises targeting gait and/or standing balance
Outcome measures
 Balance-related activities
 Quality of life
Comparisons
 Home-based exercise versus a control group receiving no intervention, usual care, or a placebo intervention
 Home-based exercise versus centre-based exercise, where the centre-based exercise is equivalent in terms of dose and type of
intervention to that of the home-based prescribed exercise
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may be superior.12–15 Two systematic reviews7,16 have presented
subgroup analyses suggesting that location may have an impact on
the effect of prescribed exercise. Shen et al7 reported that compared
with no exercise, centre-based exercise resulted in long-term im-
provements in balance and gait, while home-based exercise did not.
Similarly, Klamroth et al16 reported that home-based exercise did not
improve balance compared with no exercise. These results need to be
interpreted with caution because neither review explicitly searched
for or operationally deﬁned ‘home-based exercise’ and searches were
completed in early 2015.7,16 Therefore, relevant trials (eg, Caglar
et al17) and recently published trials (eg, Chivers Seymour et al18)
were not included. Given that the cost of fully supervised centre-
based exercise is unlikely to be sustainable in the context of a
neurodegenerative condition, it is crucial to identify whether home-
based prescribed exercise is effective.
Therefore, the research questions for this systematic review were:
1. In people with Parkinson’s disease, does home-based prescribed
exercise improve balance-related activities and quality of life
compared with no intervention?
2. Are the effects of home-based exercise similar to those of
equivalent centre-based exercise?Method
Identiﬁcation and selection of trials
A comprehensive search of the Cochrane Central Register of
Controlled Trials (CENTRAL), CINAHL, EMBASE, and Physiotherapy
Evidence Database (PEDro) databases was conducted in April 2019.
Search terms included words related to: Parkinson’s disease, phys-
iotherapy, exercise, home-based therapy, group-based therapy, su-
pervision, gait, mobility, balance, quality of life, randomised and
quasi-randomised (see Appendix 1 on the eAddenda for full search
strategy). There were no date or language restrictions. Titles and
abstracts were screened by two independent reviewers (AF, EP), po-
tential trials identiﬁed, and any conﬂicts resolved by discussionwith a
third reviewer (SD). Full copies of the relevant trials were retrieved
and reviewed by two independent reviewers (AF, EP) against pre-
determined inclusion and exclusion criteria (Box 1), with any conﬂicts
resolved by discussion with a third reviewer (SD). The reference lists
of included trials were also reviewed for potential trials.
Assessment of characteristics of the trials
Quality
The quality of the included trials was assessed using the published
PEDro score.19 The PEDro score is determined by an 11-item scale,which provides information on the internal validity of the trial and
the appropriate reporting of statistical information. Each trial is
scored out of 10, with a higher rating indicating greater methodo-
logical quality. The PEDro score was used to assess and report the
quality of the trials but no trials were excluded from the analysis
based on the PEDro score.
Participants
Trials involving adults diagnosed with Parkinson’s disease were
included, while trials involving those with Parkinsonism or Parkin-
son’s plus disorders were excluded.
Intervention
Trials were included if the intervention was exercise that was
predominantly home-based, deﬁned as two-thirds of the exercise
being conducted at home. To be included, a minimum dose of four
sessions over a minimum of 2 weeks, prescribed by a physiotherapist
or health professional with a degree-level qualiﬁcation in exercise
prescription, was required. In addition, the exercise had to primarily
involve physical practice of exercises targeting gait and/or
standing balance. Trials were excluded if the home-based exercise
was designed as a sham or control with no potential therapeutic
beneﬁt.
Trials were included when the control group received no inter-
vention, usual care, placebo or centre-based exercise. Centre-based
exercise was deﬁned as two-thirds of the exercise being provided at
a centre, such as hospital outpatient department, private practice,
medical centre or community centre. The dose and type of centre-
based exercise had to be equivalent to that of the home-based exer-
cise and be prescribed by a physiotherapist or health professional
with a degree-level qualiﬁcation in exercise prescription.
Outcomes
The primary outcome was balance-related activities. Given the
range of mobility and balance outcomes, the analysis involved pool-
ing the most comprehensive balance-related activity measure avail-
able. This was identiﬁed prior to performing the analysis using the
following priority order: MiniBESTest;20 Functional Gait Assessment21
or Dynamic Gait Index;22 Berg Balance Scale;23 Short Physical Per-
formance Battery;24 Timed Up and Go test;25 gait speed; turning
time; sit to stand time; Functional Reach test;26 single leg stand time;
Pull Test27 or Push and Release Test;28 Physical Performance Test;29
and Sensory Organisation Test.30 This method has been used in pre-
vious systematic reviews reporting mobility and balance outcomes in
Parkinson’s disease.7,31 Where a trial reported results for more than
one of these outcomes, the outcome with the highest priority was
included in the analysis. Individual balance-related outcome mea-
sures reported by three or more trials were analysed independently
Titles and abstracts screened (n = 2122)....
CENTRAL (n = 898)
CINAHL (n = 406)
EMBASE (n = 678)
PEDro (n = 140)
Potentially-relevant papers retrieved for 
evaluation of full text (n = 139)
Papers included in review (n = 17)
Trials included in meta-analysis (n = 16)
Duplicated removed (n = 726)
Papers excluded after evaluation of full text (n = 122)a.
.
.
.
.
.
.
.
.
study design not (quasi-)randomised trial (n = 7)
intervention not predominantly home-based (n = 102)
intervention not prescribed by physiotherapist or person 
with a degree-level qualification (n = 19)
intervention did not meet minimum dosage (n = 2)
intervention did not include physical practice of 
exercises targeting gait and/or standing balance (n = 12)
outcome measures were not balance-related activities or 
quality of life (n = 11)
location of the intervention was not reported (n = 7)
prescriber of the intervention was not reported (n = 16)
no relevant comparison (n = 40)
Papers excluded after screening 
titles/abstracts (n = 1257)
Figure 1. Flow of trials through the review.
a Papers may have been excluded for failing to meet more than one eligibility criterion.
Research 191as secondary outcomes. Quality of life measured using Parkinson’s
disease-speciﬁc questionnaires or other valid health-related quality of
life questionnaires was also reported as a secondary outcome
measure.
Data analysis
Data were extracted independently by two reviewers (AF, EP).
Authors were contacted where clariﬁcation for data extraction was
required. To characterise the study participants, data were extrac-
ted regarding sample size, age, time since diagnosis, measure of
disease severity (eg, Hoehn and Yahr, Uniﬁed Parkinson’s Disease
Rating Scale (UPDRS), UPDRS motor subsection, and the Movement
Disorders Society Uniﬁed Parkinson’s Disease Rating Scale (MDS-
UPDRS) Item III) and measures of cognitive ability. Details of the
intervention for the home-based prescribed exercise and compar-
ison group were extracted, including: dose and type of exercise;
medication state during training (on/off); percentage of exercise
delivered at home (home-based prescribed sessions/total pre-
scribed sessions); percentage of sessions supervised by a therapist
either in person or via teleconferencing (prescribed supervised
sessions/total prescribed sessions); and adherence (the percentage
of sessions undertaken/total prescribed sessions). The followinginformation was also extracted: outcomes used, timing of mea-
surements, medication status during measurement (on/off), and
result at each time point (mean, standard deviation and number of
participants).
Post-intervention scores and scores beyond the intervention were
used for the pooled analysis of the effect of home-based prescribed
exercise. If the results were reported as median, range and/or inter-
quartile range, the mean and standard deviation were determined
using the formula described byWan et al.32 If data were only reported
in a ﬁgure, data were extracted using the software program Web-
PlotDigitizer.33 King et al compared home-based prescribed exercise
with two centre-based exercise programs: one with individual su-
pervision and one with group supervision.15 To ensure that partici-
pants were not counted twice during the meta-analysis, each
pairwise comparison was separately included with the sample size of
the home-based prescribed exercise group equally divided. As
different outcome measures were used for balance-related activities,
gait speed, and quality of life outcomes, data were pooled using
Hedges’ g standardised mean difference with a 95% conﬁdence in-
terval. A ﬁxed-effect model was used, and each analysis was tested for
statistical heterogeneity (I2 . 50%). If heterogeneity was present, a
random-effects model was applied instead of a ﬁxed-effect model.
The analyses were performed using RevMan softwarea.
Table 1
Characteristics of included studies: home-based prescribed exercise compared with no intervention (n = 12).
Study Participantsa Intervention Supervision Adherence
(%)
Outcomesb
Allen
201034
n = 48
Age (yr) = 67 (9)
PD (yr) = 8 (6)
H & Y = N/R
UPDRS Motor = 30 (13)
MMSE = 29 (1)
Exp = Home-based (92%)
Balance and strength
40 to 60 min 3 3/wk 3 26 wk
Con = Usual care
12% supervision
1/mth group session
supervised by therapist
(centre)
1 to 2 home visits
70 SPPB
Preferred gait speed
PDQ 39
Timing: 26 wk
Ashburn
200735
n = 140
Age (yr) = 72 (9)
PD (yr) = 8 (6)
H & Y = 3.1 (0.6)
Cognitionc
Exp = Home-based (100%)
Balance, ROM, strength and
walking
60 mind 3 7/wk 3 6 wk
Con = Usual care
14% supervision
1/wk session supervised
by therapist
N/R BBS
Functional Reach
EuroQoL-5D
Timing: 8 wk, 26 wk
Caglar
200517
n = 30
Age (yr) = 66 (9)
PD (yr) = 5 (2)
H & Y = 2.1 (0.5)
Cognition = N/R
Exp = Home-based (98%)
Balance, everyday activities, ROM,
walking
60 min 3 7/wk 3 9 wk
Con = Usual care
2% supervision
1 initial session supervised
by therapist (centre)
100 Time taken to walk
10 m
Timing: 9 wk
Canning
201236
n = 20
Age (yr) = 62 (8)
PD (yr) = 6 (4)
H & Ye
UPDRS motor = 19 (9)
MMSE = 30 (0.4)
Exp = Home-based (100%)
Treadmill walking
30 to 40 min 3 4/wk 3 6 wk
Con = Usual care
29% supervision
7 sessions at home
supervised by therapist
78 Preferred gait speed
PDQ 39
Timing: 6 wk, 12 wk
Canning
20158
n = 231
Age (yr) = 71 (9)
PD (yr) = 8 (6)
H & Y = 2.7 (0.6)
UPDRS motor = 26 (10)
MMSE = 29 (1)
Exp = Home-based (92%)
Balance, cueing and strength
40 to 60 min 3 3/wk 3 26 wk
Con = Usual care
13% supervision
1/mth group session
supervised by therapist
(centre)
2 to 4 home visits
72 SPPB
Fast gait speed
PDQ 39
Timing: 26 wk
Chivers
Seymour
201918
n = 474
Age (yr) = 72 (8)
PD (yr) = 8 (6)
H & Y = 2.6 (0.9)
UPDRS motor = 33 (16)
MMSE = 29 (2)
Exp = Home-based (100%)
Balance, freezing strategies and
strength
30 min 3 7/wk 3 26 wk
Con = Usual care
7% supervision
12 sessions at home
supervised by therapist
N/R MiniBESTest
PDQ 39
Timing: 26 wk, 52 wk
Goodwin
201138
and
Fletcher
201237
n = 130
Age (yr) = 71 (8)
PD (yr) = 9 (6)
H & Y = 2.5 (0.9)
Cognitionf
Exp = Home-based (67%)
Balance and strength
60 ming 3 3/wk 3 10 wk
1/wk centre-based
2/wk home-based
Con = Usual care
33% supervision
1/wk group session
supervised by therapist
87 BBS
TUG
EuroQoL-5D
Timing:10 wk, 20 wk
Khalil
201739
n = 30
Age (yr) = 60 (14)
PD (yr) = 8 (5)
H & Y = 2.3 (0.8)
MDS UPDRS III = 48 (18)
Cognitionf
Exp = Home-based (75%)
Balance, everyday activities,
ROM, strength, and walking
45 minh 3 4/wk 3 8 wk
3/wk exercise sessions
1/wk walking
Con = Usual care
25% supervision
Wks 1 to 4, 2/wk sessions
supervised by therapist
Wks 5 to 8, 1/wk telephone
call from therapist
77 MiniBESTest
Preferred gait speed
Timing: 8 wk
Morris
201740
n = 133
Age (yr) = 71 (9)
PD (yr) = N/R
H & Y = 2.3 (0.7)
MMSE = 28 (2)
Exp = Home-based (100%)
Cueing and strength
60 min 3 2/wk 3 6 wk
Con = Placebo: life-skills program
60 min 3 2/wk 3 6 wk
50% supervision
1/wk session supervised
by therapist (home visit)
N/R PDQ39
Timing: 6 wk, 52 wk
Nieuwboer
200741
n = 153
Age (yr) = 67.5 (61.5 to 73)
PD (yr) = 8 (4 to 11)
H & Y = 3 (2.5 to 3)
UPDRS motor = 33 (25 to 41)
MMSE = 29 (27 to 30)
Exp = Home-based (100%)
Cueing during everyday activities
30 min 3 3/wk 3 3 wk
Con = Usual care
100% supervision
3/wk sessions supervised
by therapist (home visit)
100 TUG
Functional Reach
Preferred gait speed
PDQ39
Timing: 3 wk
Song
201842
n = 60
Age (yr) = 67 (7)
PD (yr) = 8 (5)
H & Y = N/R
MDS UPDRS III = 32 (12)
MMSE = 29 (2)
Exp = Home-based (100%)
Balance
15 min 3 3/wk 3 12 wk
Con = Usual care
8% supervision
2 initial home visits for set up
1 home visit at 6 weeks
Telephone call every 2 weeks
86 FGA
TUG
Timing: 12 wk
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Table 1 (Continued)
Study Participantsa Intervention Supervision Adherence
(%)
Outcomesb
Stack
201243
n = 47
Age (yr) = 74 (6)
PD (yr) = 8 (6)
H & Y = 3.1 (0.8)
UPDRS motor = 28 (13)
Cognitioni
Exp = Home-based (100%)
Cueing, everyday activities, and
strength
60 min 3 3/wk 3 4 wk
Con = No physiotherapy
100% supervision
3/wk sessions supervised
by therapist (home visit)
N/R 180 deg turn test
Functional Reach
HRQoL
Timing: 4 wk, 8 wk,
12 wk
BBS = Berg Balance Scale, FGA = Functional Gait Assessment, HRQoL = Health-related quality of life, H & Y = Hoehn and Yahr, MDS UPDRS III = Movement Disorders Society Uniﬁed
Parkinson’s Disease Rating Scale motor subsection, MMSE = Mini-Mental State Examination, MoCA = Montreal Cognitive Assessment, N/R = not reported, PDQ39 = Parkinson’s
disease Questionnaire 39, ROM = range of motion, SPPB = Short Physical Performance Battery, TUG = Timed Up and Go test, UPDRS motor = Uniﬁed Parkinson’s Disease Rating
Scale motor subsection.
a Data are n, mean (SD), or median (IQR).
b Outcomes measure and timing of outcome measures used in data analysis.
c Inclusion criterion: no gross cognitive impairment.
d Duration of intervention reported for home visits only.
e Inclusion criterion: mild Parkinson’s disease (Hoehn and Yahr stages I to II).
f Exclusion criteria: severe/marked cognitive deﬁcit.
g Duration of intervention reported for centre-based sessions only.
h Duration of intervention reported for walking component of intervention only.
i Inclusion criterion: 8/12 on the Middlesex Elderly Assessment of Mental State.
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Subgroup analyses were performed to explore the effect of dose
and supervision. With respect to dose, interventions were categorised
as high dose if they were prescribed for a minimum 150 min/wk for at
least 6 weeks. With respect to supervision, the trials that delivered
intervention with full (100%) supervision were compared with trials
that were not fully supervised.
Results
Flow of trials through the review
The search identiﬁed 1396 records (excluding duplicates). After
screening the titles and abstracts, the full texts of 139 papers were
retrieved. Of these, 17 papers8,12–15,17,18,34–43 met the inclusion
criteria. Two papers reported data from the same trial37,38 so 16 trials
were included in the meta-analysis. See Figure 1 for the ﬂow of trials
through the review.
Characteristics of included trials
Twelve trials8,17,18,34–36,38–43 involving 1496 participants compared
home-based prescribed exercise with usual care or a placebo
(Table 1). Four trials12–15 involving 204 participants compared home-
based prescribed exercise with centre-based exercise (Table 2). One of
these four trials15 compared home-based prescribed exercise with
both centre-based exercise conducted in a group and centre-based
exercise conducted individually.
Quality
The mean PEDro score of the trials was 7 (range 4 to 8) (Table 3).
All trials reported similar groups at baseline and point estimate
variability. The majority of trials (88%) reported random allocation,
assessor blinding and a loss to follow-up of , 15%. Concealed allo-
cation occurred in 75% of the trials. Only 50% of trials reported
intention-to-treat analysis. Due to the nature of the intervention it
was not possible to blind the participants or the therapists to the
intervention.
Participants
The mean age of the participants across the trials ranged from 60
to 74 years. The mean time since Parkinson’s disease diagnosis across
the trials ranged from 5 to 9 years. Fourteen trials reported disease
severity using the Hoehn and Yahr Scale and two trials34,42 used the
motor subsection of the UPDRS or MDS-UPDRS. Eight tri-
als8,18,35,38–41,43 included participants with mild to severe Parkinson’s
disease (Hoehn and Yahr stage I to IV), seven trials12–15,17,34,42
included participants with mild to moderate Parkinson’s disease
(Hoehn and Yahr stage I to III and motor subsection of the UPDRS orMDS-UPDRS) and one trial36 included participants with mild Par-
kinson’s disease (Hoehn and Yahr stage I to II). Participants with
signiﬁcant cognitive impairment were excluded in all but one trial,
which did not report a cognitive criterion for eligibility.17
Intervention
All included trials primarily involved exercises targeting gait and/
or standing balance. The exercise was prescribed by a physiotherapist
in all but one12 of the studies, where the exercise was prescribed by
an exercise physiologist. In 13 trials8,12–15,17,18,34,35,38–40,43 the exercise
program involved multiple components including: balance, cueing,
range of movement, strength, walking and everyday activities (eg, sit
to stand, turning and stairs). Three trials prescribed one exercise only:
Canning et al 201236 prescribed walking on a treadmill; Nieubower
et al41 prescribed cue training during everyday activities; and Song
et al42 prescribed balance training using an exergame that required
stepping in different directions. Five trials reported that the partici-
pants performed the exercise during the ‘on’ phase, where their
Parkinson’s disease medication was working optimally,13–15,36,42 with
the remainder not reporting medication status during exercise.
The dose of the interventions varied between the trials. The length
of the exercise programs ranged from 3 to 26 weeks, which was re-
ﬂected in the total number of prescribed sessions ranging from 9 to
182 (median 30.5). The majority of trials (63%) had an intervention
duration of between 6 to 10 weeks. Participants completed a mini-
mum of 15 minutes and a maximum of 60 minutes of prescribed
exercise per session. Nine trials8,12,14,17,18,34,35,38,39 prescribed a higher
dose of at least 150 minutes of exercise per week for at least 6 weeks.
There was a high adherence rate of  70% (range 70 to 100%) in the
ten8,13,15,17,34,36,38,39,41,42 trials where adherence was reported.
The amount of supervision provided for home-based prescribed
exercise ranged from 0 to 100%. Fifteen trials8,13–15,17,18,34–36,38–43
(93%) provided the participants with at least one supervised session
either at home or a centre prior to commencing the home exercise.
Types of supervision included individual (one participant and one
therapist) sessions at home or a centre, or group-based sessions at a
centre. One trial14 studied supervised home-based sessions using
teleconferencing (Skype). Two trials12,14 reported caregiver supervi-
sion to ensure safety of the participants when completing the home-
based exercise. All centre-based sessions were supervised.
Outcome measures
Fifteen of the trials reported that the outcome measures were
completed during the participants’ ‘on’ phase.8,12–15,17,34–36,38–43 A
measure of balance-related activities immediately after the inter-
vention was reported in 14 trials.8,12,14,15,17,18,34–36,38,39,41–43 All 14
trials reported data for a least one of the comprehensive measures of
balance-related activity listed in the priority order determined a
priori. For the meta-analysis, the following outcome measures were
Table 2
Characteristics of included studies: home-based prescribed exercise compared with centre-based exercise (n = 4).
Study Participantsa Intervention Supervision Adherence
(%)
Outcomesb
Atterbury
201712
n = 40
Age (yr) = 65 (8)
PD (yr) = 5 (7)
H & Y = 2.5 (0.5)
MDS UPDRS III = 34 (13)
MoCA = 26 (2)
Home-based (100%)
Balance
40 to 60 min 3 3/wk 3 8 wk
0% supervision
DVD with instructions and
safety guidelines
Assisted by caregiver for safety
N/R FGA
Timing: 8 wk
Centre-based
Balance exercises
40 to 60 min 3 3/wk 3 8 wk
100% supervision
3/wk sessions supervised by
therapist (group)
4 to 8 people per group
N/R
Dereli
201013
n = 30
Age (yr) = 64 (11)
PD (yr) = 7 (4)
H & Y = 2.1 (0.7)
UPDRS motor = 17 (7)
MMSE = 27 (2)
Home-based (97%)
Balance, breathing, relaxation, ROM and
walking
45 min 3 3/wk 3 10 wk
3% supervision
1 3 participant education session
1/wk telephone call from therapist
100 PDQLQ
Timing: 10 wk
Centre-based
Balance, breathing, relaxation, ROM and
walking
45 min 3 3/wk 3 10 wk
100% supervision
1 3 participant education session
3/wk sessions supervised by a
therapist (individual)
100
Gandolﬁ
201714
n = 76
Age (yr) = 69 (8)
PD (yr) = 7 (4)
H & Y = 2.5 (2.5 to 3.0)
UPDRS = 47 (24)
MMSE = 28 (4)
Home-based (95%)
Balance
50 min 3 3/wk 3 7 wk
100% supervision
1 3 explanation of intervention in centre
3/wk sessions supervised by
therapist, using Skype
Caregiver present to provide
safety
N/R DGI
Fast gait speed
PDQ8
Timing: 8 wk, 12 wk
Centre-based
Balance
50 min 3 3/wk 3 7 wk
100% supervision
3/wk sessions supervised by
therapist (individual)
N/R
King
201515
n = 58
Age (yr) = 64 (7)
PD (yr) = 6 (6)
H & Y = 2.4 (0.5)
UPDRS motor = 37 (13)
MoCA = 26 (4)
Home-based (92%)
Balance and walking
60 min 3 3/wk 3 4 wk
8% supervision
1 3 session to receive home
exercise program
85 MiniBESTest
PDQ39
Timing: 4 wk
Centre-based individual
Balance and walking
60 min 3 3/wk 3 4 wk
100% supervision
3/wk sessions supervised by
therapist (individual)
97
Centre-based group
Balance and walking
60 min 3 3/wk 3 4 wk
100% supervision
3/wk sessions supervised by
therapist (group)
95
DGI = Dynamic gait index, FGA = Functional Gait Assessment, H & Y = Hoehn and Yahr, MDS UPDRS III = Movement Disorders Society Uniﬁed Parkinson’s Disease Rating Scale motor
subsection, MMSE = Mini-Mental State Examination, MoCA = Montreal Cognitive Assessment, N/R = not reported, PDQLQ = Parkinson’s Disease Quality of Life Questionnaire, PDQ8 =
Parkinson’s disease questionnaire 8, PDQ39 = Parkinson’s disease Questionnaire 39, ROM = Range of motion, UPDRS = Uniﬁed Parkinson’s Disease Rating Scale, UPDRS motor =
Uniﬁed Parkinson’s Disease Rating Scale motor subsection.
a Data are n, mean (SD), or median (IQR).
b Outcomes measure and timing of outcome measures used in data analysis.
194 Flynn et al: Home-based exercise for Parkinson’s diseaseused: MiniBESTest,15,18,39 Functional Gait Assessment,12,42 Dynamic
Gait Index,14 Berg Balance Scale,35,38 Short Physical Performance
Battery,8,34 preferred gait speed,17,36 turning time,43 and Timed Up
and Go test.41 Gait speed, Functional Reach test and Timed Up and Go
test were the only balance-related activity outcome measures re-
ported in three or more trials with data available at the end of the
intervention only.
Four trials measured preferred gait speed,34,36,39,41 one trial
measured fast gait speed8 and one trial measured time taken to walk
10 m.17 Three trials reported Functional Reach35,41,43 and three trials
reported Timed Up and Go test.38,41,42
Quality of life was measured in 12 trials.8,13–15,18,34–36,38,40,41,43
Some trials used Parkinson’s disease-speciﬁc measures: Parkinson’s
disease Questionnaire 39 (PDQ 39),44 Parkinson’s disease question-
naire 8 (PDQ8),45 and Parkinson’s Disease Quality of Life Question-
naire (PDQLQ).46 Other trials used generic quality of life measures:
EuroQoL-5D47 and a generic health-related quality of life measure.48
Seven trials14,18,35,36,38,40,43 reported measures beyond the inter-
vention period, with the follow-up period ranging from 4 to 46 weeks
(median 10 weeks).
Effect of home-based prescribed exercise compared with usual
care or a placebo
Balance-related activities
The effect of home-based prescribed exercise on balance-related
activities immediately after the intervention was determined bypooling 11 trials totalling 1220 participants, with a mean PEDro score
of 7.2 indicating good quality. Overall, there was an SMD of 0.21 (95%
CI 0.10 to 0.32, I2 = 0%) in favour of home-based prescribed exercise
(Figure 2a, see also Figure 3a on the eAddenda for detailed forest
plot).
The effect of home-based prescribed exercise on balance-related
activities beyond the intervention period was determined by
pooling ﬁve trials totalling 541 participants, with a mean PEDro
score of 7.2 indicating good quality. The length of time after the
exercise intervention ranged from 4 to 26 weeks. One trial re-
ported follow-up data at both 4 and 8 weeks beyond the exercise,
so the values for the longest follow-up period (8 weeks) were used
in the meta-analysis. Overall, there was no difference between
home-based prescribed exercise and usual care or a placebo
beyond the intervention, with an SMD of 0.12 (95% CI 20.05 to
0.29, I2 = 0%) (Figure 2b, see also Figure 3b on the eAddenda for
detailed forest plot).
The effect of home-based prescribed exercise on gait speed
immediately after the intervention was determined by pooling six
trials totalling 482 participants, with a mean PEDro score of 7.2
indicating good quality. The overall effect was an SMD of 0.30 (95% CI
0.12 to 0.49, I2 = 3%) in favour of home-based prescribed exercise
(Figure 4, see also Figure 5 on the eAddenda for detailed forest plot).
This translates to a mean increase in gait speed of 0.12 m/s (0.01 to
0.20) when results are back converted using the largest, least-biased
and most representative study of those included in the analysis.8 Only
one trial compared the effect of home-based prescribed exercise on
Table 3
PEDro criteria and scores for included trials (n = 16).
Study Random
allocation
Concealed
allocation
Groups
similar at
baseline
Participant
blinding
Therapist
blinding
Assessor
blinding
, 15%
dropouts
Intention
-to-treat
analysis
Between-group
Difference
reported
Point estimate and
Variability
reported
Total
(0 to 10)
Allen
(2010)34
Y Y Y N N Y Y Y Y Y 8
Ashburn
(2007)35
Y Y Y N N Y Y Y Y Y 8
Atterbury
(2017)12
Y N Y N N N N N Y Y 4
Caglar
(2005)17
N N Y N N Y Y N Y Y 5
Canning
(2012)36
Y Y Y N N Y Y Y Y Y 8
Canning
(2015)8
Y Y Y N N Y Y Y Y Y 8
Chivers Seymour
(2019)18
Y Y Y N N Y Y Y Y Y 8
Dereli
(2010)13
N N Y N N Y Y N Y Y 5
Gandolﬁ
(2017)14
Y N Y N N Y Y N Y Y 6
Goodwin
(2011)38
Y Y Y N N N Y Y Y Y 7
Khalil
(2017)39
Y Y Y N N Y Y N Y Y 7
King
(2015)15
Y Y Y N N Y Y N Y Y 7
Morris
(2017)40
Y Y Y N N Y Y Y Y Y 8
Nieuwboer
(2007)41
Y Y Y N N Y Y N Y Y 7
Song
(2018)42
Y Y Y N N Y Y Y Y Y 8
Stack
(2012)43
Y Y Y N N Y N N N Y 5
Research 195gait speed beyond the intervention, so a meta-analysis could not be
performed.
There was no effect of home-based prescribed exercise on the
Functional Reach test when pooling three trials totalling 315 partic-
ipants, with a mean PEDro score of 6.7 indicating good quality (MD
0.66 cm, 95% CI 20.84 to 2.16, I2 = 0%). There was also no effect on the
Timed Up and Go test when pooling three trials totalling 330 par-
ticipants, with a mean PEDro score of 7.3 indicating good quality (MD
0.07 seconds, 95% CI 20.65 to 0.79, I2 = 28%).Quality of life
The effect of home-based prescribed exercise on quality of life
immediately after the intervention was determined by pooling nine
trials with a total of 1119 participants, with a mean PEDro score of 7.4
indicating good quality. Overall, there was a trend for home-based
prescribed exercise to improve quality of life when compared with
usual care or a placebo with an SMD of 0.11 (95% CI 20.01 to 0.23, I2 =
11%) but the data were also consistent with the possibility of an effect
close to no effect (Figure 6a, see also Figure 7a on the eAddenda for
detailed forest plot).
The effect of home-based prescribed exercise on quality of life
beyond the intervention was reported in six trials with the length of
time after the intervention ranging from 6 to 46 weeks. When pooling
data from the six trials with a total of 582 participants, with a mean
PEDro score of 7.3 indicating good quality, there was an SMD of 0.23
(95% CI 0.06 to 0.39, I2 = 22%) in favour of home-based prescribed
exercise (Figure 6b, see also Figure 7b on the eAddenda for detailed
forest plot).Subgroup analyses
Subgroup analyses were conducted for the primary outcome of
balance-related activities regarding dose and supervision. The effect
of dose on balance-related activities was determined by pooling data
from seven trials8,17,18,34,35,38,39 that delivered a high dose of inter-
vention, totalling 964 participants, with a mean PEDro score of 7.3
indicating good quality; and by pooling data from four trials36,41–43
that delivered a low dose of intervention, totalling 256 participants,
with a mean PEDro score of 7.0 indicating good quality. When trials
were grouped according to dose, high-dose home-based prescribed
exercise8,17,18,34,35,38,39 was more effective than usual care or a placebo
(SMD 0.24, 95% CI 0.11 to 0.36, I2 = 0%), and low-dose home-based
prescribed exercise36,41–43 was no more effective than usual care or a
placebo (SMD 0.11, 95% CI 20.14 to 0.36, I2 = 0%) (Figure 8, see also
Figure 9 on the eAddenda for detailed forest plot).
The effect of supervision on balance-related activities was deter-
mined by pooling data from nine trials8,17,18,34–36,38,39,42 that
examined minimally supervised exercise, totalling 1035 participants,
with a mean PEDro score of 7.4 indicating good quality; and by
pooling data from two trials41,43 that examined fully supervised ex-
ercise, totalling 185 participants, with a mean PEDro score of 6.0
indicating good quality. When trials were grouped according to su-
pervision, minimally supervised (median 13% supervised sessions,
range 2 to 33) home-based prescribed exercise8,17,18,34–36,38,39,42 was
more effective than usual care or a placebo (SMD 0.23, 95% CI 0.11 to
0.35, I2 = 0%), and fully supervised home-based prescribed exer-
cise41,43 was no more effective than usual care or a placebo (SMD 0.11,
95% CI 20.18 to 0.40, I2 = 0%) (Figure 10, see also Figure 11 on the
eAddenda for detailed forest plot).
Study
(a) end of intervention
Allen 2010
Ashburn 2007
Caglar 2005
Canning 2012
Canning 2015
Chivers Seymour 2019
Goodwin 2011
Khalil 2017
Nieuwboer 2007
Song 2018
Stack 2012
Pooled
(b) follow-up
Ashburn 2007
Canning 2012
Chivers Seymour 2019
Goodwin 2011
Stack 2012
Pooled 
SMD (95% CI)
Fixed
–0.5–1.0 0 1.00.5
Favours 
control
Favours home-
based exercise
1.5–1.5
Figure 2. a. Standardised mean difference (95% CI) of effect of home-based prescribed
exercise versus control on balance-related activities immediately after the intervention.
b. Standardised mean difference (95% CI) of effect of home-based prescribed exercise
versus control on balance-related activities beyond the intervention period.
Study
(a) end of intervention
Allen 2010
Ashburn 2007
Canning 2012
Canning 2015
Chivers Seymour 2019
Goodwin 2011
Morris 2017
Nieuwboer 2007
Stack 2012
Pooled
(b) follow-up
Ashburn 2007
Canning 2012
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Goodwin 2011
Morris 2017
Stack 2012
Pooled 
SMD (95% CI)
Fixed
–0.5–1.0 0 1.00.5
Favours 
control
Favours home-
based exercise
1.5–1.5
Figure 6. a. Standardised mean difference (95% CI) of effect of home-based prescribed
exercise versus control on quality of life immediately after the intervention.
b. Standardised mean difference (95% CI) of effect of home-based prescribed exercise
versus control on quality of life beyond the intervention period.
196 Flynn et al: Home-based exercise for Parkinson’s diseaseEffect of home-based prescribed exercise compared with
equivalent centre-based exercise
Balance-related activities
The effect of home-based prescribed exercise on balance-related
activities immediately after the intervention when compared withStudy
Allen 2010
Caglar 2005
Canning 2012
Canning 2015
Khalil 2017
Nieuwboer 2007
Pooled
SMD (95% CI)
Fixed
–0.5–1.0 0 1.00.5
Favours 
control
Favours home-
based exercise
1.5–1.5
Figure 4. Standardised mean difference (95% CI) of effect of home-based prescribed
exercise versus control on gait speed immediately after the intervention.equivalent centre-based exercise was determined by pooling three
trials12,14,15 totalling 166 participants, with a mean PEDro score of 5.7
indicating fair quality. Overall, there was no effect on balance-related
activities for home-based prescribed exercise when compared with
centre-based exercise (SMD 20.04, 95% CI 20.36 to 0.27, I2 = 0%)
(Figure 12, see also Figure 13 on the eAddenda for detailed forest
plot). There were no individual mobility and balance outcome mea-
sures reported by three or more trials.
Quality of life
The effect of home-based prescribed exercise on quality of life
immediately after the intervention when compared with equivalent
centre-based exercise was determined by pooling three trials13–15
totalling 157 participants, with a mean PEDro score of 6.0 indi-
cating good quality. Overall, there was no effect on quality of life for
home-based prescribed exercise when compared with centre-based
exercise (SMD 20.08, 95% CI 20.41 to 0.24, I2 = 5%) (Figure 14, see
also Figure 15 on the eAddenda for detailed forest plot).
Discussion
This systematic review provides evidence that home-based pre-
scribed exercise improves balance-related activities and gait speed in
people with mild to moderate Parkinson’s disease without substantial
cognitive deﬁcit. These improvements were not sustained beyond the
intervention period. There is also a trend for home-based prescribed
exercise to improve quality of life for this population. When
comparing centre-based exercise with home-based prescribed exer-
cise, neither model of care was superior to the other for balance-
Study
(a) high dose
Allen 2010
Ashburn 2007
Caglar 2005
Canning 2015
Chivers Seymour 2019
Goodwin 2011
Khalil 2017
Pooled
(b) low dose
Canning 2012
Nieuwboer 2007
Song 2018
Stack 2012
Pooled 
SMD (95% CI)
Fixed
–0.5–1.0 0 1.00.5
Favours 
control
Favours home-
based exercise
1.5–1.5
Figure 8. Subgroup analysis by dose on the effect of home-based prescribed exercise
versus control on balance-related activities immediately after the intervention.
Study
(a) 100% supervised
Nieuwboer 2007
Stack 2012
Pooled
(b) ≤33% supervised
Allen 2010
Ashburn 2007
Caglar 2005
Canning 2012
Canning 2015
Chivers Seymour 2019
Goodwin 2011
Khalil 2017
Song 2018
Pooled 
SMD (95% CI)
Fixed
–0.5–1.0 0 1.00.5
Favours 
control
Favours home-
based exercise
1.5–1.5
Figure 10. Subgroup analysis by supervision on the effect of home-based prescribed
exercise versus control on balanced-related activities immediately after the intervention.
Study
Atterbury 2017
Gandolfi 2017
King 2015
King 2015a
Pooled
SMD (95% CI)
Fixed
–0.5–1.0 0 1.00.5
Favours centre-
based exercise
Favours home-
based exercise
1.5–1.5
Figure 12. Standardised mean difference (95% CI) of effect of home-based prescribed
exercise versus centre-based exercise on balance-related activities immediately after
the intervention.
Research 197related activities or quality of life. The majority of the trials (75%)
included in the meta-analysis were of high quality, which supports
the credibility of these ﬁndings.
This is the ﬁrst systematic review to speciﬁcally investigate the
effectiveness of home-based prescribed exercise in people with Par-
kinson’s disease. The small positive effect in balance-related activities
is consistent with previous systematic reviews7,16,31 investigating the
effect of exercise, irrespective of the location. Furthermore, the
ﬁnding that the beneﬁts on balance-related activities gained from
home-based prescribed exercise were not sustained beyond the
intervention in this review is also consistent with a subgroup analysis
conducted by Shen et al,7 who reported no long-term effect on bal-
ance and gait when exercise was home-based.
Home-based prescribed exercise improved gait speed. When
converted from an SMD to m/s, the increase in gait speed (0.12 m/s)
was greater than previously reported in systematic reviews: Allen
et al31 reported an increase of 0.05 m/s, and Tomlinson et al4 reported
an increase of 0.04 m/s. Both Allen et al and Tomlinson et al included
studies of low methodological quality, whereas ﬁve of the six trials in
the current review were of good quality. Furthermore, four trials
included in the current meta-analysis had a speciﬁc focus on walking,
compared with the previous reviews, which included a greater range
of interventions, including dance, Tai Chi and cueing strategies. This
suggests that the greater increase in gait speed could be, in part, due
to the speciﬁcity of the training. This increase in gait speed could also
be considered clinically signiﬁcant, given it is well above the 0.06 m/s
reported by Hass et al to be a small clinically important difference in
people with Parkinson’s disease.49
The lack of difference in quality of life immediately after the
intervention extends the previous work conducted by Tomlinson
et al,4 which reported that physiotherapy did not have an effect on
quality of life. One explanation for this could be that the home-based
exercise focused primarily on addressing the motor impairments of
Parkinson’s disease; however, non-motor impairments (such as
depression) have been shown to have a greater effect on quality of lifethan motor impairments.50 Nevertheless, the improvement in quality
of life beyond the intervention period reﬂects some ongoing beneﬁt
of home-based exercise.
The subgroup analysis by dose indicates that the amount of the
intervention is important when prescribing home-based exercise for
people with Parkinson’s disease, as high-dose interventions (mini-
mum 150 min/wk for at least 6 weeks) improved balance-related
activities while low-dose interventions did not. This is the ﬁrst
meta-analysis to show that dose inﬂuences outcomes of exercise
programs in people with Parkinson’s disease, and differs from the
only other meta-analysis considering dose.7 This difference may have
been due to the deﬁnition of high dose used in the current analysis,
where dose was deﬁned by both duration and frequency (ie, 150 min/
wk over a minimum of 6 weeks) compared with Shen et al who
considered dose based on the number of hours completed.7 The
current results suggest that prescribed exercise should be sustained
Study
Dereli 2010
Gandolfi 2017
King 2015
King 2015a
Pooled
SMD (95% CI)
Fixed
–0.5–1.0 0 1.00.5
Favours centre-
based exercise
Favours home-
based exercise
1.5–1.5
Figure 14. Standardised mean difference (95% CI) of effect of home-based prescribed
exercise versus centre-based exercise on quality of life immediately after the
intervention.
198 Flynn et al: Home-based exercise for Parkinson’s diseasefor a minimum of 150 min/wk for 6 weeks, and that if prescribed
exercises are not ongoing, the improvements in balance-related ac-
tivities will not be maintained. The ongoing need for prescribed ex-
ercise is supported by Wallen et al, who showed that improvements
in balance were only maintained up to 6 months beyond the inter-
vention in people with Parkinson’s disease.51 Importantly, a high dose
of home-based prescribed exercise was provided with minimal su-
pervision, which did not impact the effectiveness of the intervention.
This indicates that prescribed exercise for people with Parkinson’s
disease can be provided in a sustainable manner over the long term.
The subgroup analysis by supervision found no effect of fully su-
pervised home-based exercise programs, while programs with min-
imal supervision improved balance-related activities. However, the
home-based exercise programs included in the fully supervised tri-
als were of low dose (ie, an average of 135 minutes of exercise a week
for an average of 3.5 weeks) compared with the home-based exercise
programs included in the minimally supervised trials (ie, an average
of 208 minutes of exercise a week for an average of 14 weeks).
Furthermore, the trials with high dose had the lowest amount of
supervision, with the average supervision over the seven trials being
15%. It is possible that the requirement for an exercise program to be
fully supervised at home negatively inﬂuences the dose that can be
achieved due to resource constraints. Given that Parkinson’s disease
is a chronic progressive condition, it is vital that effective exercise
programs can be delivered and monitored without requiring full
supervision.
The second question in this review was to determine if home-
based prescribed exercise improves balance-related activities and
quality of life when compared with centre-based exercise in people
with Parkinson’s disease. Our results indicate that when exercise type
and dose are equivalent, the effects on balance-related activities and
quality of life are similar between centre-based and home-based
prescribed exercise immediately after the intervention. Our review
included four trials that directly compared home-based prescribed
exercise and centre-based exercise of equivalent type and dose,
ensuring that the results can be attributed primarily to location.
These results should be applied cautiously because the overall quality
of these trials was fair. Any differences beyond the intervention
period could not be determined due to insufﬁcient data.
This review has clinical implications for physiotherapists working
with people with Parkinson’s disease. Importantly, home-based pre-
scribed exercise is effective in people with mild to moderate Par-
kinson’s disease without substantial cognitive impairment, and that
effect is likely to be similar in magnitude to centre-based exercise.
This allows clinicians to consider the best location for intervention
based on the preference of the person with Parkinson’s disease and
the resources available. It is important to note that all the home-
based exercise programs were prescribed by a physiotherapist or
health professional with a degree-level qualiﬁcation in exercise pre-
scription, and the majority of the home-based exercise programsincorporated therapist support and/or direct supervision using a va-
riety of methods, including: home visits by the therapist, occasional
group-based sessions at a centre, telephones calls and Skype. In nine
of the 12 trials, where home-based prescribed exercise was compared
with usual care or a placebo, it included a minimum of one home
visit. These strategies enable the therapist to provide feedback and
progress the exercises to ensure that they remained appropriate and
challenging.
The results of this review support minimally supervised, home-
based exercise to improve balance-related activities in people with
mild to moderate Parkinson’s disease without substantial cognitive
impairment. However, three fall-prevention trials suggest that this
type of exercise may increase falls in those with more advanced
Parkinson’s disease,8,18,35 cognitive impairment and freezing of gait.18
Therefore, minimally supervised, home-based exercise is not rec-
ommended for people with more advanced Parkinson’s disease,
especially in the presence of cognitive impairment and freezing of
gait.
This review had some limitations, including the use of post-
intervention data as opposed to change scores and the use of an
SMD, which is less clinically meaningful than a mean difference. For
the analysis examining the effect of home-based prescribed exercise
compared with usual care or a placebo beyond the intervention, there
were few trials and the follow-up period was highly variable, so these
results should be applied cautiously. When comparing home-based
prescribed exercise with centre-based exercise, the few available
trials all had small sample sizes, which could have led to small sample
bias. The reporting of adherence to the intervention also needs to be
considered, as the trials with minimal supervision relied on self-
reporting and no trials reported if adherence was calculated using
capped (ie, capped data, restricting adherence to a maximum of
100%) or uncapped (ie, uncapped data, allowing . 100% adherence)
methods. As expected, there was a wide range of balance-related
activity measures reported; greater consistency of outcome mea-
sures would facilitate future research.52 The use of a predeﬁned pri-
ority order was an effective method of addressing this concern.
In conclusion this review provides evidence that home-based
prescribed exercise can improve balance-related activities and gait
speed in people with mild to moderate Parkinson’s disease without
substantial cognitive deﬁcit. Furthermore, these improvements are
likely to be similar to improvements obtained by equivalent centre-
based exercise. This suggests that home-based prescribed exercise
may be an effective strategy for delivering high-quality exercise to
people with Parkinson’s disease in health services where resources
are limited.What was already known on this topic: In people with
Parkinson’s disease, specific exercise-based interventions
improve mobility, balance and quality of life. Given the progres-
sive nature of the disease and its near-normal life expectancy,
exercise programs must be sustainable. Home-based prescribed
exercise has the potential to be sustained over a long period of
time with minimal resources.
What this study adds: Home-based prescribed exercise im-
proves balance and gait speed in people with Parkinson’s dis-
ease. Home-based and centre-based exercise were found to have
similar effects on balance-related activities and quality of life.
Footnotes: a RevMan 5.3 software, The Nordic Cochrane Centre,
Copenhagen, Denmark.
eAddenda: Figures 3, 5, 7, 9, 11, 13 and 15, and Appendix 1 can be
found online at https://doi.org/10.1016/j.jphys.2019.08.003.
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